Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / American Depositary Shares
-
Shares outstanding
-
11,337,576
-
Total 13F shares
-
442,094
-
Share change
-
+132,291
-
Total reported value
-
$2,314,216
-
Price per share
-
$6.75
-
Number of holders
-
10
-
Value change
-
+$887,634
-
Number of buys
-
7
-
Number of sells
-
1
Institutional Holders of KAZIA THERAPEUTICS LTD - American Depositary Shares (KZIA) as of Q3 2020
As of 30 Sep 2020,
KAZIA THERAPEUTICS LTD - American Depositary Shares (KZIA) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
442,094 shares.
The largest 10 holders included
MORGAN STANLEY, Transform Wealth, LLC, RENAISSANCE TECHNOLOGIES LLC, TRUIST FINANCIAL CORP, HighPoint Advisor Group LLC, WELLS FARGO & COMPANY/MN, UBS Group AG, ACADIAN ASSET MANAGEMENT LLC, Steward Partners Investment Advisory, LLC, and BREWIN DOLPHIN LTD.
This page lists
10
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.